← Back to Search

Procedure: Acupuncture for Post-Traumatic Stress Disorder (PTSD ACU Trial)

N/A

Waitlist Available

Led By Michael Hollifield, MD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 12 weeks

Awards & highlights

PTSD ACU Trial Summary

This trial will test whether acupuncture can help treat symptoms of PTSD in veterans, by comparing it to sham acupuncture.

Eligible Conditions

Post-Traumatic Stress Disorder

PTSD ACU Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in PTSD Symptom Severity on the Clinician Administered PSTD Scale - CAPS 5 From Before to After Treatment

Secondary outcome measures

Percentage Change From Baseline in Eyeblink Startle Potentiation

PTSD ACU Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Verum acupunctureExperimental Treatment1 Intervention

Traditional Chinese Medicine (TCM) based acupuncture at prescribed sites

Group II: Minimal needlingPlacebo Group1 Intervention

shallow and non-acupoint needles at same number of sites

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Procedure: Acupuncture

2018

N/A

~100

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor

1,610 Previous Clinical Trials

3,305,092 Total Patients Enrolled

Analydata, IncUNKNOWN

1 Previous Clinical Trials

360 Total Patients Enrolled

Michael Hollifield, MDPrincipal InvestigatorVA Long Beach Healthcare System, Long Beach, CA

2 Previous Clinical Trials

450 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the eligibility criteria for this medical experiment exclude individuals over fifty-five years old?

"In order to be accepted for this clinical trial, patients must fall between 18 and 55 years of age as stipulated by the eligibility criteria."

Answered by AI

Are there any opportunities for me to participate in this research?

"This clinical trial requires 93 volunteers aged 18-55 that are suffering from PTSD, who also meet the following criteria: Veterans age 18 to 55, CAPS-5 score of at least 26 and experiencing all 4 symptom clusters, DSM-5 diagnosis for chronic PTSD according to the Clinician Administered PTSD Scale (CAPS-5)."

Answered by AI

Are participants being sought for this trial at present?

"According to the information found on clinicaltrials.gov, this particular medical trial is not actively recruiting patients at present. Initially posted in April 2018 and most recently edited in August 2022, it does not appear that this research project needs any additional participants right now; however, 411 other trials are still searching for volunteers."

Answered by AI

Recent research and studies

TrialsJournal

Acupuncture for Combat Post-traumatic Stress Disorder: Trial Development and Methodological Approach for a Randomized Controlled Clinical Trial

Hollifield, Michael, An-Fu Hsiao, Kala Carrick, Andrea Gory Munoz, Teresa Calloway, Karen Cocozza, Besa Smith, et al.. 2021. “Acupuncture for Combat Post-traumatic Stress Disorder: Trial Development and Methodological Approach for a Randomized Controlled Clinical Trial”. Trials. Springer Science and Business Media LLC. doi:10.1186/s13063-021-05394-3.

clinicaltrials.govStudy

Acupuncture for PTSD

2018. "Acupuncture for PTSD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02869646.